Yahoo Web Search

Search results

    • Here's Why Eli Lilly Stock Remains a Screaming Buy

      Here's Why Eli Lilly Stock Remains a Screaming Buy

      Motley Fool via Yahoo Finance· 13 minutes ago

      More additional indications for tirzepatide could also be on the way. Lilly expects to file for U.S. approval of the drug in treating heart failure with ...